Skip to main content

Erickson Financial Group, LLC

Location
ALLENTOWN, PA
Portfolio Value
Micro $17,774,619
Diversification
Highly concentrated
Filing Date
Global Rank
#7,452 / 8,232 ▲ 197
Top Industry
Drug Manufacturers - General 41.9%
3Y Alpha vs SPY
+2.3%
Period ended 2 months ago
Filed Apr 8, 2026 · 2mo
18 quarters · since Dec 2021

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+92.3%
SPY
+76.5%
Annualised alpha
+3.5%
Max drawdown
−21.7%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

6 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
74.4%
−0.3 pts
Top 5
98.4%
−0.1 pts
Top 10
100.0%
0.0 pts
HHI
5,770
Jun 2023 → Mar 2026 · range 5,342 – 6,066
Highly concentrated−52

Portfolio Trend

18 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Unclassified 88.1% $15,657,692
Technology 5.3% $939,997
Healthcare 5.0% $888,050
Consumer Defensive 1.6% $288,880

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
3 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
1 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
No qualifying positions this quarter.

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
6 positions · $17,774,619 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History